Analyst Research Report Snapshot

Title:

EVOLVA - BECAUSE IT'S WORTH IT

Price:

$10.00

Provider:

Edison Investment Research

Date:

12 Feb 2014

Pages:

3

Type:

AcrobatPDF

Companies referenced:

EVE.S

Available for Immediate Download
Summary:

Evolva’s new collaboration with L’Oréal further demonstrates the potential of Evolva’s yeast technology platform. Limited details have been disclosed, but the two companies will co-develop a biosynthetic way to manufacture a cosmetic ingredient that is strategically important to L’Oréal and has broad applications. To produce the compound, Evolva will create a novel pathway, which the company could use subsequently to expand its proprietary pipeline. We raise our valuation to CHF1.78/share.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.